Co-Diagnostics Inc $ 12.14 1.58 (14.96%)
Volume:
10,890,138
Avg Vol (1m):
2,239,147
Market Cap $:
343.19 Mil
Enterprise Value $:
315.91 Mil
P/E (TTM):
13.49
P/B:
6.81
Financial Strength | 10/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | No Debt | ||
| Equity-to-Asset | 0.97 | ||
| Interest Coverage | No Debt | ||
| Piotroski F-Score | 7 | ||
| Altman Z-Score | 113.48 | ||
| Beneish M-Score | 360.03 | ||
| WACC vs ROIC | |||
Profitability Rank | 1/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 50.59 | ||
| Net Margin % | 58.79 | ||
| ROE % | 126.56 | ||
| ROA % | 118.8 | ||
| ROC (Joel Greenblatt) % | 319.51 | ||
| 3-Year EBITDA Growth Rate | -34.4 | ||
| 3-Year EPS without NRI Growth Rate | -27.4 |
CODX
Valuation Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 13.49 | ||
| Forward PE Ratio | 6.78 | ||
| PE Ratio without NRI | 13.49 | ||
| Price-to-Owner-Earnings | 47.8 | ||
| PB Ratio | 6.81 | ||
| PS Ratio | 7.42 | ||
| Price-to-Free-Cash-Flow | 77.82 | ||
| Price-to-Operating-Cash-Flow | 73.65 | ||
| EV-to-EBIT | 12.81 | ||
| EV-to-EBITDA | 12.75 | ||
| EV-to-Revenue | 6.75 | ||
| Current Ratio | 28.64 | ||
| Quick Ratio | 22.72 | ||
| Days Inventory | 128.69 | ||
| Days Sales Outstanding | 81.73 | ||
| Days Payable | 7.4 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -15.8 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 6.82 | ||
| Price-to-Graham-Number | 2.02 | ||
| Earnings Yield (Greenblatt) % | 7.92 |